Clinical trial
Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After…
NCT00107874 · University Hospital, Basel, Switzerland, Other · Completed
Key facts
| NCT number | NCT00107874 |
|---|---|
| Title | Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-scheduled Cesarean Section |
| Official title | Oral Misoprostol as a Second-line Alternative to Intravenous Oxytocin in Preventing Postoperative Blood Loss After Non-scheduled Cesarean Section: a Randomized, Double-blind, Placebo-controlled Trial |
| Lead sponsor | University Hospital, Basel, Switzerland, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postpartum Hemorrhage |
| Intervention type | Drug |
| Interventions | misoprostol |
| Enrollment | 56 |
| Start date | Jan 1, 1999 |
| Primary completion | Feb 1, 2002 |
| Completion | Feb 1, 2002 |
| First posted | Apr 12, 2005 |
| Last update posted | Apr 4, 2019 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: